Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6677712 | 0.79 | GPR3 (0.32) | GPR3 | |
| SCHEMBL6672322 | 0.72 | GPR3 (0.32) | GPR3 | |
| SCHEMBL6675415 | 0.72 | — | — | |
| SCHEMBL9632059 | 0.69 | GPR3 (0.40) | GPR3 | |
| SCHEMBL6672430 | 0.68 | GPR3 (0.43) | GPR3 | |
| SCHEMBL6671925 | 0.67 | GPR3 (0.46) | GPR3 | |
| SCHEMBL30390148 | 0.67 | GPR3 (0.46) | GPR3 | |
| SCHEMBL5175634 | 0.67 | GPR3 (0.46) | GPR3 | |
| SCHEMBL5981387 | 0.67 | GPR3 (0.46) | GPR3 | |
| SCHEMBL6675584 | 0.67 | GPR3 (0.35) | GPR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0963990-B1 | PROCESS FOR PRODUCING CYCLOPENTADIENYL METAL SALTS AND PROCESS FOR PRODUCING CYCLOPENTADIENE DERIVATIVES BY UTILIZING THE SAME | SUMITOMO CHEMICAL CO (JP) | 2004-10-06 | — | — | EP | disclosed |
| US-6197990-B1 | REACTING CYCLOPENTADIENE AND METAL HYDRIDE IN PRESENCE OF AMINE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-03-06 | — | — | US | disclosed |
| EP-0963990-A1 | PROCESS FOR PRODUCING CYCLOPENTADIENYL METAL SALTS AND PROCESS FOR PRODUCING CYCLOPENTADIENE DERIVATIVES BY UTILIZING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1999-12-15 | — | — | EP | disclosed |